RESEARCHER PROFILE

Bahil Ghanim

← Back to Karl Landsteiner University of Health Sciences

B

Karl Landsteiner University of Health Sciences

Pulmonary Hypertension Research and TreatmentsOccupational and environmental lung diseasesTransplantation: Methods and OutcomesLung Cancer Diagnosis and TreatmentLung Cancer Research Studies

Bahil Ghanim works in Pulmonary Hypertension Research and Treatments, Occupational and environmental lung diseases, Transplantation: Methods and Outcomes, Lung Cancer Diagnosis and Treatment, Lung Cancer Research Studies. Recorded institutional associations include Karl Landsteiner University of Health Sciences.

97Publications
2,685Citations
33H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertension

    2018 · 141 citations
  2. Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis

    2015 · 134 citations
  3. Primary Lung Transplantation After Bridge With Extracorporeal Membrane Oxygenation

    2012 · 132 citations
  4. Distinct Differences in Gene Expression Patterns in Pulmonary Arteries of Patients with Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis with Pulmonary Hypertension

    2014 · 126 citations
  5. Extracorporeal membrane oxygenation support for complex tracheo-bronchial procedures†

    2014 · 117 citations
  6. Evolution of outcome and complications in TAVR: a meta-analysis of observational and randomized studies

    2020 · 105 citations
  7. Compartment-specific expression of collagens and their processing enzymes in intrapulmonary arteries of IPAH patients

    2015 · 96 citations
  8. Targeting TMEM16A to reverse vasoconstriction and remodelling in idiopathic pulmonary arterial hypertension

    2019 · 83 citations
  9. Subtype-specific KRAS mutations in advanced lung adenocarcinoma: A retrospective study of patients treated with platinum-based chemotherapy

    2014 · 73 citations
  10. Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonia (NSIP) and organ donors

    2013 · 72 citations
  11. Loss of SMAD3 Promotes Vascular Remodeling in Pulmonary Arterial Hypertension via MRTF Disinhibition

    2017 · 69 citations
  12. Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma

    2014 · 67 citations
  13. Meprin β, a novel mediator of vascular remodelling underlying pulmonary hypertension

    2013 · 66 citations
  14. Fibroblast Growth Factor Receptor Inhibition Is Active against Mesothelioma and Synergizes with Radio- and Chemotherapy

    2014 · 66 citations
  15. Prognostic significance of telomerase-associated parameters in glioblastoma: effect of patient age

    2013 · 66 citations
  16. High‐mobility group box‐1 induces vascular remodelling processes via c‐Jun activation

    2015 · 61 citations
  17. Treprostinil inhibits proliferation and extracellular matrix deposition by fibroblasts through cAMP activation

    2018 · 60 citations
  18. Importance of kynurenine in pulmonary hypertension

    2017 · 56 citations
  19. Lung Cancer in Never Smokers

    2011 · 54 citations
  20. Pretreatment Serum C-Reactive Protein Levels Predict Benefit From Multimodality Treatment Including Radical Surgery in Malignant Pleural Mesothelioma

    2012 · 48 citations
  21. Endothelin-1 driven proliferation of pulmonary arterial smooth muscle cells is c-fos dependent

    2014 · 48 citations
  22. Resident cell lineages are preserved in pulmonary vascular remodeling

    2018 · 48 citations
  23. NPY / Y 1 receptor‐mediated vasoconstrictory and proliferative effects in pulmonary hypertension

    2014 · 47 citations
  24. Temsirolimus Inhibits Malignant Pleural Mesothelioma Growth In Vitro and In Vivo: Synergism with Chemotherapy

    2011 · 47 citations
  25. Disconnect between Fibrotic Response and Right Ventricular Dysfunction

    2018 · 46 citations

← Return to the university profile